A randomised trial to evaluate the immunogenicity, reactogenicity, and safety of the 10-valent pneumococcal non-typeable Haemophilus influenzaeprotein D conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Singapore and Malaysia

BACKGROUND: The immunogenicity, reactogenicity, and safety of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines were evaluated among infants from Singapore and Malaysia, where PHiD-CV has been licensed...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Infect Dis
Auteurs principaux: Lim, Fong Seng, Koh, Mia Tuang, Tan, Kah Kee, Chan, Poh Chong, Chong, Chia Yin, Shung Yehudi, Yeo Wee, Teoh, Yee Leong, Shafi, Fakrudeen, Hezareh, Marjan, Swinnen, Kristien, Borys, Dorota
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2014
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4286912/
https://ncbi.nlm.nih.gov/pubmed/25278086
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-14-530
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires